MAPT and Alzheimer disease: Collectively, these studies demonstrate that overexpression of δ-secretase elicits both APP and Tau cleavage and leads to AD-like pathologies and cognitive impairments in hAPP/hMAPT double-transgenic mice regardless of APP or Tau mutation.